Digital Discovery Platform for Organic Electronics Materials
Develop a digital platform to streamline the discovery and commercialization of molecular materials for organic electronics, enhancing efficiency through virtual screening and supply chain integration.
Projectdetails
Introduction
We propose to develop and commercialize a digital platform to accelerate the discovery and deployment of molecular materials in the broad sector of organic and printed electronics. This sector, with enormous market potential, is limited by the slow and inefficient development of new materials.
Technology Overview
Using this platform, functional materials for a specific purpose are discovered through virtual screening with predictions benchmarked against a continuously growing number of experimental data. The technology samples the space of all molecules that are commercially available and their synthetically feasible analogues.
Platform Features
The platform provides a one-stop-shop solution from digital discovery to experimental verification by linking the candidates identified via virtual screening with the chemical supply chain and the procurement of such candidates.
Key Advantages
- The size of the chemical space explored is unprecedented in organic electronics.
- Validation of screening methods against experiments is a significant feature.
- The link with the supply chain enhances the efficiency of material deployment.
Collaboration
This project is brought together by the University of Liverpool, who developed the database and the underlying validation methodology, NANOMATCH, provider of modelling solutions to the organic electronics sector, and MCULE, aggregating one of the largest purchasable chemical spaces for organic compounds.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.294.000 |
Totale projectbegroting | € 1.294.000 |
Tijdlijn
Startdatum | 1-5-2022 |
Einddatum | 30-4-2025 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- MCULE.COM KFTpenvoerder
- NANOMATCH GMBH
- THE UNIVERSITY OF LIVERPOOL
Land(en)
Vergelijkbare projecten binnen EIC Transition
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Targeting cardiac fibrosis with next generation RNA therapeuticsFIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness. | EIC Transition | € 2.499.482 | 2022 | Details |
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationSThe NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring. | EIC Transition | € 2.497.750 | 2022 | Details |
Predictive REagent-Antibody Replacement Technology stage 2-TranslationPRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment. | EIC Transition | € 800.000 | 2022 | Details |
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stageDeveloping a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships. | EIC Transition | € 2.499.810 | 2022 | Details |
Targeting cardiac fibrosis with next generation RNA therapeutics
FIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness.
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationS
The NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring.
Predictive REagent-Antibody Replacement Technology stage 2-Translation
PRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment.
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stage
Developing a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Unique ALD/MLD-Enabled Material FunctionsUniEn-MLD aims to innovate metal-organic materials through advanced ALD/MLD techniques, enabling unique functionalities for applications in magnetic storage and energy solutions. | ERC ADG | € 2.499.645 | 2023 | Details |
Design and synthesis of bulk-active polymeric organic electrocatalysts for efficient electroorganic synthesisPolyElectroCAT aims to develop earth-abundant, carbon-based electrode materials for efficient electroorganic synthesis, enhancing selectivity and reducing reliance on precious metals. | ERC STG | € 1.500.000 | 2024 | Details |
In-situ & operando organiC electrochemical transistors monitored by non-destructive spectroscopies for Organic cmos-like NeuromorphIc CircuitsICONIC aims to advance implantable AI organic electronic devices for chronic disease management by investigating PMIECs, leading to smart drug-delivery systems with enhanced accuracy and safety. | EIC Pathfinder | € 2.664.940 | 2024 | Details |
Launch of a universal sublimation technology for molecular transfer on SUBstratesSmolSUB aims to revolutionize organic electronics by developing a low-cost, eco-friendly sublimation method for creating versatile devices like OLEDs and sensors, facilitating commercialization. | ERC POC | € 150.000 | 2023 | Details |
Unique ALD/MLD-Enabled Material Functions
UniEn-MLD aims to innovate metal-organic materials through advanced ALD/MLD techniques, enabling unique functionalities for applications in magnetic storage and energy solutions.
Design and synthesis of bulk-active polymeric organic electrocatalysts for efficient electroorganic synthesis
PolyElectroCAT aims to develop earth-abundant, carbon-based electrode materials for efficient electroorganic synthesis, enhancing selectivity and reducing reliance on precious metals.
In-situ & operando organiC electrochemical transistors monitored by non-destructive spectroscopies for Organic cmos-like NeuromorphIc Circuits
ICONIC aims to advance implantable AI organic electronic devices for chronic disease management by investigating PMIECs, leading to smart drug-delivery systems with enhanced accuracy and safety.
Launch of a universal sublimation technology for molecular transfer on SUBstrates
SmolSUB aims to revolutionize organic electronics by developing a low-cost, eco-friendly sublimation method for creating versatile devices like OLEDs and sensors, facilitating commercialization.